Value of Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma
ConditionBreast Fibroadenoma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorAssiut University
About this trial
assess the efficacy of MWA in reducing fibroadenoma volume and achieving complete lesion regression at 12 months post-treatment
Eligibility criteria
Qualifiers
Female participants ≥ 18 years
Diagnosed with fibroadenoma by clinical and ultrasonographic signs, core needle biopsy done only if atypical fibroadenoma.
Lesion(s) measurable by ultrasound (e.g., diameter 0.7 - 3.0 cm),distance from breast lesion to the skin and pectoralis muscle exceeding 10 mm and the lesion away from nipple areola area .
Symptomatic lesion or patient preference for minimally invasive treatment
Disqualifiers
Malignancy or high suspicion of malignancy, BIRADs 4 or more/if pathological proved.
Active infection.
Coagulopathy or contraindications to ablation.
Distance from breast lesion to the skin and pectoralis muscle less than 10 mm and the lesion near nipple areola area .
Trial design
Treatments tested in this trial
- microwave ablation
Treatment groups
45 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov